Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget …

U Siebert, M Arvandi, RM Gothe, B Bornschein… - Heart, Lung and …, 2014 - Elsevier
Purpose The international multicentre FAME Study (n= 1,005) demonstrated significant
health benefits for patients undergoing multivessel percutaneous coronary intervention (PCI) …

Economic evaluation of fractional flow reserve–guided percutaneous coronary intervention in patients with multivessel disease

WF Fearon, B Bornschein, PAL Tonino, RM Gothe… - Circulation, 2010 - Am Heart Assoc
Background—The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation
(FAME) study demonstrated significantly improved health outcomes at 1 year in patients …

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study

WF Fearon, PAL Tonino, B De Bruyne, U Siebert… - American heart …, 2007 - Elsevier
BACKGROUND: Although its limitations for diagnosing critical coronary artery disease are
well described, coronary angiography remains the predominant method for guiding …

Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised …

LX van Nunen, FM Zimmermann, PAL Tonino… - The Lancet, 2015 - thelancet.com
Summary Background In the Fractional Flow Reserve Versus Angiography for Multivessel
Evaluation (FAME) study, fractional flow reserve (FFR)-guided percutaneous coronary …

Clinical outcomes and cost-effectiveness of fractional flow reserve–guided percutaneous coronary intervention in patients with stable coronary artery disease: three …

WF Fearon, T Nishi, B De Bruyne, DB Boothroyd… - Circulation, 2018 - Am Heart Assoc
Background: Previous studies found that percutaneous coronary intervention (PCI) does not
improve outcome compared with medical therapy (MT) in patients with stable coronary artery …

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided …

FM Zimmermann, B De Bruyne, NHJ Pijls, M Desai… - American heart …, 2015 - Elsevier
Background Guidelines recommend coronary artery bypass graft (CABG) surgery over
percutaneous coronary intervention (PCI) for the treatment of 3-vessel coronary artery …

Prognosis and medical cost of measuring fractional flow reserve in percutaneous coronary intervention

D Hong, SH Lee, D Shin, KH Choi, HK Kim, TK Park… - JACC: Asia, 2022 - jacc.org
Background There are limited data regarding comparative prognosis and medical cost
between fractional flow reserve (FFR)–based and angiography-based percutaneous …

Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve

WF Fearon, D Shilane, NHJ Pijls, DB Boothroyd… - Circulation, 2013 - Am Heart Assoc
Background—The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation
(FAME) 2 trial demonstrated a significant reduction in subsequent coronary …

The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel …

HS Lim, PAL Tonino, B De Bruyne, ASC Yong… - International journal of …, 2014 - Elsevier
Background Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI)
improved outcomes compared with an angiography-guided strategy in patients with …

Long-term cost-effectiveness of fractional flow reserve–based percutaneous coronary intervention in stable and unstable angina

D Hong, H Kim, H Lee, J Lee, J Cho, D Shin, SH Lee… - JACC: Advances, 2022 - jacc.org
Background There are limited studies on the cost-effectiveness of fractional flow reserve
(FFR)-based percutaneous coronary intervention (PCI) over angiography-based PCI …